Evidence map›Paper›PMID 25010054›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2014

Utility before business.

Steven M Teutsch, Jonathan E Fielding, Muin J Khoury, James P Evans

Abstract readComment

In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.Breast care (Basel, Switzerland) · 2022
Review

4 · The record

Corrections and comments

Comment on
The business of genomic testing: a survey of early adopters.2014

5 · Who and what money

Authors and funding

4 authors.

Steven M TeutschDepartment of Public Health, Los Angeles County, Los Angeles, California, USA.

Jonathan E Fielding1] Department of Public Health, Los Angeles County, Los Angeles, California, USA [2] Fielding School of Public Health, University of California, Los Angeles, California, USA [3] Schools of Medicine, University of California, Los Angeles, California, USA.

Muin J Khoury1] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA [2] Epidemiology and Genomics Research Program, National Cancer Institute, Bethesda, Maryland, USA.

James P EvansSchool of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.

Funding

North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2U01HG006487 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, POWELL, BRADFORD C. · 2012 to 2021

$22.7M

Intramural CDC HHS CC999999NHGRI NIH HHS U01 HG006487

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GenomicsGenetic TestingHumansNeoplasms

Identifiers

PMID25010054

DOI10.1038/gim.2014.71

PMCPMC4690454

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.